SUMMARY The role of estimating the serum carcinoembryonic antigen (CEA) in the diagnosis and prognosis of retinoblastoma cases has been evaluated. Although the mean serum CEA titre in children with retinoblastoma was higher than that in control children (p=O0O1), the serum CEA level itself was found not to be a useful marker in the diagnosis of retinoblastoma. A significant correlation of serum CEA titre with progression or regression of the disease observed during therapy in most cases indicated that serial assays of serum CEA may be important in the follow-up of cases with retinoblastoma. The lower CEA values in aqueous humour and subretinal fluid from eyes with retinoblastoma than in the serum suggests that the tumour does not secrete the CEA.
level itself was found not to be a useful marker in the diagnosis of retinoblastoma. A significant correlation of serum CEA titre with progression or regression of the disease observed during therapy in most cases indicated that serial assays of serum CEA may be important in the follow-up of cases with retinoblastoma. The lower CEA values in aqueous humour and subretinal fluid from eyes with retinoblastoma than in the serum suggests that the tumour does not secrete the CEA.
The detection of tumour-associated antigens in serum or body fluids has been the subject of recent interest in the diagnosis and follow-up of malignant tumours.' Elevated serum levels of one of these antigens, carcinoembryonic antigen (CEA), have been described in many malignant conditions,' 2 especially colorectal and pancreatic carcinomas, and also recently in many nonmalignant conditions.' So far only a few studies have emphasised the role ofCEA in retinoblastoma.34
In the present study we aimed to find out the usefulness of measuring the serum CEA level in the diagnosis and prognosis of retinoblastoma cases.
Materials and methods
Twelve cases of histologically proved retinoblastoma (age range 1 year 5 months to 5 years 2 months) seen at the Regional Institute of Ophthalmology, Calcutta, were included in this study. The diagnosis of retinoblastoma was made on the basis of clinical history, ocular and systemic examination, slit-lamp biomicroscopy, ophthalmoscopy, and radiography of the skull and orbits, together with estimation of lactate dehydrogenase (LDH) and the electrophoretic protein pattern ofthe aqueous in cases where aqueous collection was possible from the intact anterior chamber. All these cases underwent enucleation or Correspondence to Dr I. S. Roy, Director, Regional Institute of Ophthalmology, Medical College, Calcutta 700 073, India. exenteration, and the eyeballs were subjected to histopathological examination for the confirmation of diagnQsis. After operation the patients were treated with radiotherapy or chemotherapy or both depending on the histopathological extent of the tumour and assessment of any developing metastatic nodules. Cases were followed up for every month for a period of 6 months. In 3 cases gamma scan for detection of bony metastases was perfonned.
In 11 of these patients the serum CEA levels were estimated before enucleation or exenteration and 2 weeks after and then at intervals in selected cases. In one case no pre-enucleation value for serum CEA was available.
The sera from 10 children (age range 1 to 5 years) with congenital cataract (6), Coats's disease (2), endophthalmitis (1) , and retinal detachment (1) were also collected for control serum CEA values. In selecting the control children diseases that come into the differential diagnosis of retinoblastoma were included, as this was considered to be a better control population than age-matched normal children (Felberg, personal communication, 1982) .
The sera samples were stored at -20°C, and CEA levels were measured with a radioimmunoassay kit (Phadebas CEA PRIST, Pharmacia Diagnostics). Counting was done on a Beckman Gamma Counter (model Gamma 4000).
In addition, from 4 patients with retinoblastoma the pre-enucleation sera and aqueous specimens from 252 the enucleated eyeballs were also subjected to CEA children showed serum CEA levels above 50
assay. In 2 of these 4 eyes the subretinal fluid (SRF) Agll.
was collected by paracentesis of the intact globe for In S (cases I to 5) out of 12 children the serum CEA CEA estimation.5 Aqueous humour and subretinal titre dropped significantly 2 weeks after surgery, and fluid samples were obtained with a 25-gauge needle no recurrence of metastasis was noted within 6 attached to a dry tuberculin syringe. These samples months in them except in one case (case 3) ( Table 2) . were stored and processed in the same way as the This group included 2 cases with histological evidence serum samples.
of optic nerve invasion, and both needed postoperative radiotherapy. In the other 6 cases (cases 6
Results to l1) the CEA titre continued to rise even after surgery, and these mostly included children with The mean serum CEA titre in children with retino-proptosis and metastases. The spread of the disease blastoma (75 ,ug/l) was higher than the mean serum was reflected in the immediate rise of the post-CEA titre in control children (2-77 p.g/l) ( (Table 2) . As shown in Table 3 , the CA values for serum were higher than those for intraocular fluids in the small group of cases in which they were compared. The concentrations of CEA in 2 samples of subretinal fluid were almost similar to the aqueous CEA levels.
Discussion
Though in comparison with the control children the retinoblastoma cases showed a significantly higher (p=001) mean serum CEA value, the individual serum CEA values in 44 5% of the children with retinoblastoma overlapped the individual CEA values of the control children. Therefore the serum CEA level itself was not a significant diagnostic marker for retinoblastoma. Michelson et al. 3 have made a similar observation. This limitation of the diagnostic value of the serum CEA may not be unique for retinoblastoma, since other investigators have also observed that some of the diagnosed malignant neoplastic conditions might be associated with normal serum CEA values. 6 A decrease of the serum CEA titre following surgery indicates a good prognosis, as the incidence of recurrence or metastasis is low in such cases. A similar fall of the serum CEA level after surgery in other malignant conditions has been ascribed to the decrease in the tumour burden.' However, the source of CEA is retinoblastoma is probably not the tumour, 3 and so the concept of decrease in the tumour burden may not be applicable. Most Although, apparently, CEA may not be produced by the tumour, it is possible that the release of a chemical mediator from the tumour may diffuse into the circulation and so stimulate the synthesis of CEA in other target organs.3 Even with this possibility, the tumour bulk may be controlling the synthesis of CEA indirectly through the controlled production of the chemical mediator.
